TIDMGSK

RNS Number : 0730T

GlaxoSmithKline PLC

15 July 2020

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                  Ms E Walmsley 
====  =====================================  ==================================================== 
 b)    Position/status                       Chief Executive Officer 
====  =====================================  ==================================================== 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ==================================================== 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ==================================================== 
 b)    Nature of the                         Increase in notional interest in Ordinary 
        transaction                           Shares following the re-investment of dividends 
                                              paid to shareholders on 9 July 2020 on 
                                              Ordinary Shares held in the Company's Deferred 
                                              Annual Bonus Plan. 
====  =====================================  ==================================================== 
 c)    Price(s) and                          Price(s)                     Volume(s) 
        volume(s) 
====  =====================================  ===========================  ===================== 
                                             GBP 15.9280                  788 
 ==========================================  ===========================  ===================== 
                                             GBP 15.9280                  784 
                                             ===========================  ===================== 
                                             GBP 15.9280                  631 
                                             ===========================  ===================== 
 
 d)    Aggregated information                2,203 
==== 
 
    Aggregated volume                          GBP15.9280 
    Price 
 ==========================================  ==================================================== 
 e)    Date of the transaction               2020-07-13 
====  =====================================  ==================================================== 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                    Dr H Barron 
====  =======================================  =================================================== 
 b)    Position/status                         Chief Scientific Officer and President, 
                                                R&D 
====  =======================================  =================================================== 
 c)    Initial notification/                   Initial notification 
        amendment 
====  =======================================  =================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  =================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  =================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                          American Depositary Shares ('ADSs') 
        the financial                           ISIN: US37733W1053 
        instrument 
====  =======================================  =================================================== 
 b)    Nature of the                           Increase in notional interest in ADSs following 
        transaction                             the re-investment of dividends paid to 
                                                shareholders on 9 July 2020 on ADSs held 
                                                in the Company's Deferred Annual Bonus 
                                                Plan. 
====  =======================================  =================================================== 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  =======================================  =========================  ====================== 
                                               $ 40.3700                  455 
 ============================================  =========================  ====================== 
                                               $40.3700                   357 
                                               =========================  ====================== 
 
 d)    Aggregated information                  812 
==== 
 
    Aggregated volume                            $40.3700 
    Price 
 ============================================  =================================================== 
 e)    Date of the transaction                 2020-07-13 
====  =======================================  =================================================== 
 f)    Place of the                            New York Stock Exchange (XNYS) 
        transaction 
====  =======================================  =================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                  Mr R Connor 
====  =====================================  ==================================================== 
 b)    Position/status                       President, Global Vaccines 
====  =====================================  ==================================================== 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ==================================================== 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ==================================================== 
 b)    Nature of the                         Increase in notional interest in Ordinary 
        transaction                           Shares following the re-investment of dividends 
                                              paid to shareholders on 9 July 2020 on 
                                              Ordinary Shares held in the Company's Deferred 
                                              Annual Bonus Plan. 
====  =====================================  ==================================================== 
 c)    Price(s) and                          Price(s)                     Volume(s) 
        volume(s) 
====  =====================================  ===========================  ===================== 
                                             GBP 15.9280                  199 
 ==========================================  ===========================  ===================== 
                                             GBP 15.9280                  205 
                                             ===========================  ===================== 
                                             GBP 15.9280                  167 
                                             ===========================  ===================== 
 
 d)    Aggregated information                571 
==== 
 
    Aggregated volume                          GBP15.9280 
    Price 
 ==========================================  ==================================================== 
 e)    Date of the transaction               2020-07-13 
====  =====================================  ==================================================== 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                  Ms D Conrad 
====  =====================================  ====================================================== 
 b)    Position/status                       SVP Human Resources 
====  =====================================  ====================================================== 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ====================================================== 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ====================================================== 
 b)    Nature of the                         Increase in notional interest in Ordinary 
        transaction                           Shares following the re-investment of dividends 
                                              paid to shareholders on 9 July 2020 on 
                                              Ordinary Shares held in the Company's Deferred 
                                              Annual Bonus Plan. 
====  =====================================  ====================================================== 
 c)    Price(s) and                           Price(s)                      Volume(s) 
        volume(s) 
====  =====================================   ============================  ===================== 
   GBP 15.9280                                                              82 
   =======================================================================  ===================== 
 
 d)    Aggregated information                N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ====================================================================  ============================ 
 e)    Date of the transaction               2020-07-13 
====  =====================================  ====================================================== 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ====================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                   Mr J Ford 
====  ======================================  ====================================================== 
 b)    Position/status                        Senior Vice President and General Counsel 
====  ======================================  ====================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ====================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ====================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 July 2020 on 
                                               Ordinary Shares held in the Company's Deferred 
                                               Annual Bonus Plan. 
====  ======================================  ====================================================== 
 c)    Price(s) and                            Price(s)                     Volume(s) 
        volume(s) 
====  ======================================   ===========================  ====================== 
   GBP15.9280                                                               117 
   =======================================================================  ====================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ====================================================================  ============================= 
 e)    Date of the transaction                2020-07-13 
====  ======================================  ====================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ====================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                    Mr J Ford 
====  =======================================  ==================================================== 
 b)    Position/status                         Senior Vice President and General Counsel 
====  =======================================  ==================================================== 
 c)    Initial notification/                   Initial notification 
        amendment 
====  =======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  ==================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                          American Depositary Shares ('ADSs') 
        the financial                           ISIN: US37733W1053 
        instrument 
====  =======================================  ==================================================== 
 b)    Nature of the                           Increase in notional interest in ADSs following 
        transaction                             the re-investment of dividends paid to 
                                                shareholders on 9 July 2020 on ADSs held 
                                                in the Company's Deferred Annual Bonus 
                                                Plan. 
====  =======================================  ==================================================== 
 c)    Price(s) and                             Price(s)                   Volume(s) 
        volume(s) 
====  =======================================   =========================  ====================== 
                                                $ 40.3700                  39 
                                                =========================  ====================== 
 
 d)    Aggregated information                  N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ========================================  ======================================================== 
 e)    Date of the transaction                 2020-07-13 
====  =======================================  ==================================================== 
 f)    Place of the                            New York Stock Exchange (XNYS) 
        transaction 
====  =======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                  Mr N Hirons 
====  =====================================  ==================================================== 
 b)    Position/status                       SVP, Global Ethics & Compliance 
====  =====================================  ==================================================== 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ==================================================== 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ==================================================== 
 b)    Nature of the                         Increase in notional interest in Ordinary 
        transaction                           Shares following the re-investment of dividends 
                                              paid to shareholders on 9 July 2020 on 
                                              Ordinary Shares held in the Company's Deferred 
                                              Annual Bonus Plan. 
====  =====================================  ==================================================== 
 c)    Price(s) and                          Price(s)                     Volume(s) 
        volume(s) 
====  =====================================  ===========================  ===================== 
                                             GBP 15.9280                  87 
 ==========================================  ===========================  ===================== 
                                             GBP 15.9280                  86 
                                             ===========================  ===================== 
                                             GBP 15.9280                  61 
                                             ===========================  ===================== 
 
 d)    Aggregated information                234 
==== 
 
    Aggregated volume                          GBP 15.9280 
    Price 
 ==========================================  ==================================================== 
 e)    Date of the transaction               2020-07-13 
====  =====================================  ==================================================== 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                  Ms S Jackson 
====  =====================================  ====================================================== 
 b)    Position/status                       SVP, Global Communications & CEO Office 
====  =====================================  ====================================================== 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ====================================================== 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ====================================================== 
 b)    Nature of the                         Increase in notional interest in Ordinary 
        transaction                           Shares following the re-investment of dividends 
                                              paid to shareholders on 9 July 2020 on 
                                              Ordinary Shares held in the Company's Deferred 
                                              Annual Bonus Plan. 
====  =====================================  ====================================================== 
 c)    Price(s) and                           Price(s)                      Volume(s) 
        volume(s) 
====  =====================================   ============================  ===================== 
   GBP 15.9280                                                              49 
   =======================================================================  ===================== 
 
 d)    Aggregated information                N/A (single transaction) 
==== 
 
    Aggregated volume                     GBP 15.9280 
    Price 
 =====================================  =========================================================== 
 e)    Date of the transaction               2020-07-13 
====  =====================================  ====================================================== 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ====================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                  Mr I Mackay 
====  =====================================  ====================================================== 
 b)    Position/status                       Chief Financial Officer 
====  =====================================  ====================================================== 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ====================================================== 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ====================================================== 
 b)    Nature of the                         Increase in notional interest in Ordinary 
        transaction                           Shares following the re-investment of dividends 
                                              paid to shareholders on 9 July 2020 on 
                                              Ordinary Shares held in the Company's Deferred 
                                              Annual Bonus Plan. 
====  =====================================  ====================================================== 
 c)    Price(s) and                           Price(s)                      Volume(s) 
        volume(s) 
====  =====================================   ============================  ===================== 
   GBP 15.9280                                                              426 
   =======================================================================  ===================== 
 
 d)    Aggregated information                N/A (single transaction) 
==== 
 
    Aggregated volume                     GBP 15.9280 
    Price 
 =====================================  =========================================================== 
 e)    Date of the transaction               2020-07-13 
====  =====================================  ====================================================== 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ====================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                    Mr B McNamara 
====  =======================================  =================================================== 
 b)    Position/status                         CEO, GSK Consumer Healthcare 
====  =======================================  =================================================== 
 c)    Initial notification/                   Initial notification 
        amendment 
====  =======================================  =================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  =================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  =================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                          American Depositary Shares ('ADSs') 
        the financial                           ISIN: US37733W1053 
        instrument 
====  =======================================  =================================================== 
 b)    Nature of the                           Increase in notional interest in ADSs following 
        transaction                             the re-investment of dividends paid to 
                                                shareholders on 9 July 2020 on ADSs held 
                                                in the Company's Deferred Annual Bonus 
                                                Plan. 
====  =======================================  =================================================== 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ---------------------------------------  =========================  ====================== 
                                               $ 40.3700                  76 
 --------------------------------------------  =========================  ====================== 
                                               $ 40.3700                  81 
                                               =========================  ====================== 
                                               $ 40.3700                  65 
                                               -------------------------  ---------------------- 
 
 
 d)    Aggregated information                  222 
==== 
 
    Aggregated volume                            $ 40.3700 
    Price 
 ============================================  =================================================== 
 e)    Date of the transaction                 2020-07-13 
====  =======================================  =================================================== 
 f)    Place of the                            New York Stock Exchange (XNYS) 
        transaction 
====  =======================================  =================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr L Miels 
====  ======================================  ==================================================== 
 b)    Position/status                        President, Global Pharmaceuticals 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 July 2020 on 
                                               Ordinary Shares held in the Company's Deferred 
                                               Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP15.9280                  158 
 ===========================================  ==========================  ====================== 
                                              GBP15.9280                  191 
                                              ==========================  ====================== 
                                              GBP15.9280                  219 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 568 
==== 
 
    Aggregated volume                           GBP15.9280 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-07-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr D Redfern 
====  ======================================  ==================================================== 
 b)    Position/status                        Chief Strategy Officer 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 July 2020 on 
                                               Ordinary Shares held in the Company's Deferred 
                                               Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP15.9280                  162 
 ===========================================  ==========================  ====================== 
                                              GBP15.9280                  194 
                                              ==========================  ====================== 
                                              GBP15.9280                  140 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 496 
==== 
 
    Aggregated volume                           GBP15.9280 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-07-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr R Simard 
====  ======================================  ==================================================== 
 b)    Position/status                        President, Pharmaceuticals Supply Chain 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 July 2020 on 
                                               Ordinary Shares held in the Company's Deferred 
                                               Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP15.9280                  99 
 ===========================================  ==========================  ====================== 
                                              GBP15.9280                  70 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 169 
==== 
 
    Aggregated volume                           GBP15.9280 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-07-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                    Ms K Terrell 
====  =======================================  =================================================== 
 b)    Position/status                         Chief Digital & Technology Officer 
====  =======================================  =================================================== 
 c)    Initial notification/                   Initial notification 
        amendment 
====  =======================================  =================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  =================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  =================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                          American Depositary Shares ('ADSs') 
        the financial                           ISIN: US37733W1053 
        instrument 
====  =======================================  =================================================== 
 b)    Nature of the                           Increase in notional interest in ADSs following 
        transaction                             the re-investment of dividends paid to 
                                                shareholders on 9 July 2020 on ADSs held 
                                                in the Company's Deferred Annual Bonus 
                                                Plan. 
====  =======================================  =================================================== 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  =======================================  =========================  ====================== 
                                               $ 40.3700                  27 
 ============================================  =========================  ====================== 
                                               $ 40.3700                  97 
                                               =========================  ====================== 
                                               $40.3700                   66 
                                               =========================  ====================== 
 
 d)    Aggregated information                  190 
==== 
 
    Aggregated volume                            $ 40.3700 
    Price 
 ============================================  =================================================== 
 e)    Date of the transaction                 2020-07-13 
====  =======================================  =================================================== 
 f)    Place of the                            New York Stock Exchange (XNYS) 
        transaction 
====  =======================================  =================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr P Thomson 
====  ======================================  ==================================================== 
 b)    Position/status                        President, Global Affairs 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 July 2020 on 
                                               Ordinary Shares held in the Company's Deferred 
                                               Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP15.9280                  109 
 ===========================================  ==========================  ====================== 
                                              GBP15.9280                  113 
                                              ==========================  ====================== 
                                              GBP15.9280                  80 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 302 
==== 
  Aggregated volume                           GBP15.9280 
   Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-07-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHVELBFBDLLBBK

(END) Dow Jones Newswires

July 15, 2020 04:31 ET (08:31 GMT)

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Gsk
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Gsk